HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Marketing Round-Up: Launches From Healthspan, Lanes, A Vogel And Dermal

Executive Summary

Healthspan adds New Zealand blackcurrant supplement to Elite range; Lanes Health brings Nordic iron supplement to UK, A Vogel offers British consumers an eco-friendly eye dropper version of Pollinosan; and Dermal Laboratories launches Doublebase Once.  

You may also be interested in...



Lanes Health Leans Further Into Naturals Trend With UK Olbas Extension

The UK's Lanes Health continues to invest in naturals with the latest extension to decongestant range, Olbas Breathe Easy Patches.

EU Business News: Orkla Acquires Healthspan, Bayer Invests Locally, Ipsen Targets Baltics

A round-up of the latest European consumer health business news: Norway's Orkla strengthens its supplements offering with acquisition of UK's Healthspan; Bayer makes investment commitment to German Consumer Health operation; and Ipsen strikes a deal to promote brands in the Baltics.

Top 10 UK OTC Marketing Stories 2021: Switches And Digital Prove Popular

Despite the restrictions on daily life due to the pandemic, 2021 was still a great year for consumer health product marketing, with brands and their agencies devising innovative ways to reach UK consumers. Here we look at HBW Insight's top-10 most read UK marketing stories of 2021, revealing those launches, campaigns and trends which grabbed the attention of readers last year.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152506

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel